Published in Clin Cancer Res on May 01, 2005
Can urinary exosomes act as treatment response markers in prostate cancer? J Transl Med (2009) 2.14
Urine biomarkers in prostate cancer. Nat Rev Urol (2010) 1.17
Toward the detection of prostate cancer in urine: a critical analysis. J Urol (2012) 1.13
Telomerase as an important target of androgen signaling blockade for prostate cancer treatment. Mol Cancer Ther (2010) 0.93
Markers for detection of prostate cancer. Cancers (Basel) (2010) 0.82
Clinical significance of telomerase activity in peritoneal disseminated cells: gastrointestinal cancers. Mol Med (2008) 0.75
Progesterone activates the principal Ca2+ channel of human sperm. Nature (2011) 3.18
Acid extrusion from human spermatozoa is mediated by flagellar voltage-gated proton channel. Cell (2010) 2.73
In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol (2004) 2.50
Deficits in urological knowledge among medical students and primary care providers: potential for impact on urological care. J Urol (2008) 2.27
Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J Biol Chem (2010) 1.74
Diagnosis of bladder cancer with microelectromechanical systems-based cystoscopic optical coherence tomography. Urology (2009) 1.69
Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res (2004) 1.66
Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer. Cancer Lett (2009) 1.30
Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J Urol (2006) 1.04
Membrane type 1-matrix metalloproteinase promotes human prostate cancer invasion and metastasis. Thromb Haemost (2005) 1.03
The chemokine receptor CXCR4 as a novel independent prognostic marker for node-positive breast cancer patients. J Surg Oncol (2012) 0.92
Does obesity have an effect on outcomes in triple-negative breast cancer? J Surg Res (2013) 0.89
Prostate cancer cell adhesion to bone marrow endothelium: the role of prostate-specific antigen. Cancer Res (2004) 0.88
Are patients aware of the association between smoking and bladder cancer? J Urol (2006) 0.82
Endoscopic treatment of bladder calculi in post-renal transplant patients: a 10-year experience. J Endourol (2004) 0.81
Morbid obesity does not disadvantage patients with in situ or early-stage carcinoma undergoing breast-conserving surgery. Anticancer Res (2013) 0.80
Carcinoma of the axillary tail of Spence: a case series. Anticancer Res (2012) 0.78
Is chronic kidney disease an independent risk factor for mortality in breast cancer? J Surg Res (2013) 0.78
Laparoscopic resection of small bowel sarcoma. Surg Laparosc Endosc Percutan Tech (2013) 0.77
Bladder wall abscess following midurethral sling procedure. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.76
Immunocompetent orthotopic pancreatic cancer murine model: a step in the right direction. J Surg Res (2011) 0.75
Wilm's tumor during pregnancy: report of laparoscopic removal and review of literature. Can J Urol (2008) 0.75
Granulocytic sarcoma of the adrenal gland. Can J Urol (2009) 0.75
Imaging findings of successful and failed fundoplication. Radiographics (2014) 0.75
Is baseline bone imaging in high-risk breast cancer patients justified? Breast J (2012) 0.75
Evaluating the Effectiveness of the General Surgery Intern Boot Camp. Am Surg (2016) 0.75
Sebaceous carcinoma of the right arm. J La State Med Soc (2012) 0.75
Should a routine metastatic workup be performed for all patients with pathologic N2/N3 breast cancer? J Am Coll Surg (2012) 0.75
Effect of January vacations and prior night call status on resident ABSITE performance. J Surg Educ (2013) 0.75
Highly sensitive revealing of PCR products with capillary electrophoresis based on single photon detection. Biosens Bioelectron (2006) 0.75